Cargando…
Hashimoto’s thyroiditis following SARS-CoV-2 infection
Infectious diseases have long been considered one of the triggers for autoimmune and autoinflammatory diseases. Since the appearance of the new coronavirus in December 2019 in the city of Wuhan, China, there have been many reports suggesting that infection with coronavirus 2 (SARS-CoV-2) precedes th...
Autores principales: | Knack, Rafael Silvestre, Hanada, Taliê, Knack, Renata Silvestre, Mayr, Kamilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354276/ https://www.ncbi.nlm.nih.gov/pubmed/34373245 http://dx.doi.org/10.1136/bcr-2021-244909 |
Ejemplares similares
-
Preliminary results of clinical use of colchicine in COVID-19 treatment
por: Knack, Rafael Silvestre, et al.
Publicado: (2021) -
The Use of Liraglutide in Obese Patients With COVID-19: A Case Report
por: Hanada, Taliê Zanchetta Buani, et al.
Publicado: (2021) -
Successful Management of Subacute Thyroiditis Following SARS-CoV-2 Infection
por: Sato, Daisuke, et al.
Publicado: (2021) -
Iridium-related deep levels in n-type silicon
por: Bollmann, J, et al.
Publicado: (2000) -
Immune Response to SARS-CoV-2 Vaccine and Following Breakthrough Omicron Infection in an Autoimmune Patient with Hashimoto’s Thyroiditis, Pernicious Anemia, and Chronic Atrophic Autoimmune Gastritis: A Case Report
por: Cluff, Emily, et al.
Publicado: (2022)